Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Epidemiology and Population Health

Higher erythrocyte n-3 polyunsaturated fatty acid were associated with a better profile of DXA-derived body fat and fat distribution in adults

Subjects

Abstract

Background

Previous studies have reported that high-dose supplementation of n-3 polyunsaturated fatty acids (PUFAs) may reduce the risk of metabolic diseases, but there is limited evidence of an effect on body fat. We examined the associations of erythrocyte n-3 PUFAs with body fat and fat distribution in a general population consuming a normal diet.

Methods

This community-based cross-sectional study included 3075 Chinese (68% women, 40–75 years) recruited between 2008 and 2013. We collected general information and measured anthropometric indices; erythrocyte n-3 PUFAs (including α-C18:3, C20:5, C22:5 and C22:6) by gas-chromatography, and fat mass (FM) and %FM at the total body (TB), android (A) and gynoid (G) regions by dual-energy X-ray absorptiometry (DXA).

Results

Both minimally and maximally adjusted models showed dose-dependent inverse associations of total and individual levels of erythrocyte n-3 PUFAs (except C20:5 n-3[EPA]) with adiposity indices. In the full model, the mean differences between quartiles 4 and 1 of total n-3 PUFAs were −1.60% (BMI), −4.06% (TB FM), −5.38% (A FM), −2.05% (G FM), −2.05% (TB %FM), −3.39% (A %FM) and −2.50% (% A/G); the ORs (95% CI) of %FM-derived obesity (≥25% for men, ≥35% for women) for the highest (vs. lowest) quartile were 0.70 (0.57, 0.86) for total n-3 PUFAs and 0.71 (0.58, 0.87), 0.96(0.78, 1.18), 0.82(0.67, 1.00), 0.66 (0.54, 0.81) for α-C18:3/C20:5/C22:5/C22:6 n-3, respectively. The favourable associations were more pronounced for the DXA-derived FM indices, measurements at the android region and for C22:6 n-3. No significant associations between C20:5 n-3 and the adiposity indices were observed.

Conclusions

Higher levels of circulating n-3 PUFAs were dose-dependently associated with better profiles of body fat and fat distribution, particularly in the abdominal regions in this population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Regions of abdomen (A region) and hip and thigh region (G region) fat as assessed by DXA.
Fig. 2: Percentage mean (change) differences and its standard errors for indices of body fat and fat distribution by quartiles of total and individual erythrocyte n-3 PUFAs levels.
Fig. 3: The odds ratios (ORs) and 95% confidential intervals (95% CI) of %FM-derived obesity for quartiles 2–4 compared with quartile 1 (lowest) of each and total n-3 PUFAs.

Similar content being viewed by others

References

  1. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–67.

    Article  CAS  PubMed  Google Scholar 

  2. Hill JH, Solt C, Foster MT. Obesity associated disease risk: the role of inherent differences and location of adipose depots. Horm Mol Biol Clin Investig. 2018;33:1868–91.

    Google Scholar 

  3. Piche ME, Poirier P, Lemieux I, Despres JP. Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update. Prog Cardiovasc Dis. 2018;61:103–13.

    Article  PubMed  Google Scholar 

  4. Sethi JK, Vidal-Puig AJ. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007;48:1253–62.

    Article  CAS  PubMed  Google Scholar 

  5. Lorente-Cebrian S, Costa AG, Navas-Carretero S, Zabala M, Martinez JA, Moreno-Aliaga MJ. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J Physiol Biochem. 2013;69:633–51.

    Article  CAS  PubMed  Google Scholar 

  6. Abete I, Goyenechea E, Zulet MA, Martinez JA. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis. 2011;21(Suppl 2):1–15.

    Article  CAS  Google Scholar 

  7. Buckley JD, Howe PR. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev. 2009;10:648–59.

    Article  CAS  PubMed  Google Scholar 

  8. Buckley JD, Howe PR. Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review. Nutrients. 2010;2:1212–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Albracht-Schulte K, Kalupahana NS, Ramalingam L, Wang S, Rahman SM, Robert-McComb J, et al. Omega-3 fatty acids in obesity and metabolic syndrome: a mechanistic update. J Nutr Biochem. 2018;58:1–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wang L, Manson JE, Rautiainen S, Gaziano JM, Buring JE, Tsai MY, et al. A prospective study of erythrocyte polyunsaturated fatty acid, weight gain, and risk of becoming overweight or obese in middle-aged and older women. Eur J Nutr. 2016;55:687–97.

    Article  CAS  PubMed  Google Scholar 

  11. Harris WS, Pottala JV, Lacey SM, Vasan RS, Larson MG, Robins SJ. Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study. Atherosclerosis. 2012;225:425–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Micallef M, Munro I, Phang M, Garg M. Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr. 2009;102:1370–4.

    Article  CAS  PubMed  Google Scholar 

  13. Howe PR, Buckley JD, Murphy KJ, Pettman T, Milte C, Coates AM. Relationship between erythrocyte omega-3 content and obesity is gender dependent. Nutrients. 2014;6:1850–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Zhuang P, Lu Y, Shou Q, Mao L, He L, Wang J, et al. Differential anti-adipogenic effects of eicosapentaenoic and docosahexaenoic acids in obesity. Mol Nutr Food Res. 2019; https://doi.org/10.1002/mnfr.201801135.

  15. Jakobsen MU, Dethlefsen C, Due KM, Slimani N, Chajes V, May AM, et al. Plasma phospholipid long-chain n-3 polyunsaturated fatty acids and body weight change. Obes Facts. 2011;4:312–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Jakobsen MU, Madsen L, Skjoth F, Berentzen TL, Halkjaer J, Tjonneland A, et al. Dietary intake and adipose tissue content of long-chain n-3 PUFAs and subsequent 5-year change in body weight and waist circumference. Am J Clin Nutr. 2017;105:1148–57.

    Article  CAS  PubMed  Google Scholar 

  17. Hastert TA, Otto MCD, Le-Scherban F, Steffen BT, Steffen LM, Tsai MY, et al. Association of plasma phospholipid polyunsaturated and trans fatty acids with body mass index: results from the multi-ethnic study of atherosclerosis. Int J Obes. 2018;42:433–40.

    Article  CAS  Google Scholar 

  18. Bender N, Portmann M, Heg Z, Hofmann K, Zwahlen M, Egger M. Fish or n3-PUFA intake and body composition: a systematic review and meta-analysis. Obes Rev. 2014;15:657–65.

    Article  CAS  PubMed  Google Scholar 

  19. Couet C, Delarue J, Ritz P, Antoine JM, Lamisse F. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes Relat Metab Disord. 1997;21:637–43.

    Article  CAS  PubMed  Google Scholar 

  20. Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, Moore CS, et al. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes. 2006;30:1535–44.

    Article  CAS  Google Scholar 

  21. DeFina LF, Marcoux LG, Devers SM, Cleaver JP, Willis BL. Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. Am J Clin Nutr. 2011;93:455–62.

    Article  CAS  PubMed  Google Scholar 

  22. Hill AM, Buckley JD, Murphy KJ, Howe PR. Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. Am J Clin Nutr. 2007;85:1267–74.

    Article  CAS  PubMed  Google Scholar 

  23. Kabir M, Skurnik G, Naour N, Pechtner V, Meugnier E, Rome S, et al. Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr. 2007;86:1670–9.

    Article  CAS  PubMed  Google Scholar 

  24. Yamaoka S, Fujimoto M, Mori M, Mori H, Yamori Y. Risk reduction of lifestyle-related diseases in young adults on soy- or fish-rich traditional japanese meals. Clin Exp Pharmacol Physiol. 2007;34:S79–81.

    Article  Google Scholar 

  25. Jang H, Park K. Omega-3 and omega-6 polyunsaturated fatty acids and metabolic syndrome: a systematic review and meta-analysis. Clin Nutr. 2019; https://doi.org/10.1016/j.clnu.2019.03.032.

  26. Zheng JS, Huang T, Yang J, Fu YQ, Li D. Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis. PloS One. 2012;7:e44525.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Raatz SK, Conrad Z, Johnson LK, Picklo MJ, Jahns L. Relationship of the reported intakes of fat and fatty acids to body weight in US adults. Nutrients. 2017;9:438.

    Article  PubMed Central  CAS  Google Scholar 

  28. Lentjes M, Mulligan A, Welch AA, Bhaniani A, Luben R, Khaw KT. Contribution of cod liver oil‐related nutrients (vitamins A, D, E and eicosapentaenoic acid and docosahexaenoic acid) to daily nutrient intake and their associations with plasma concentrations in the EPIC‐Norfolk cohort. J Hum Nutr Diet. 2015;28:568–82.

    Article  CAS  PubMed  Google Scholar 

  29. Shen X, Fang AP, He JJ, Liu ZQ, Guo MH, Gao R, et al. Trends in dietary fat and fatty acid intakes and related food sources among Chinese adults: a longitudinal study from the China Health and Nutrition Survey (1997-2011). Public Health Nutr. 2017;20:2927–36.

    Article  PubMed  Google Scholar 

  30. FAO/WHO. Expert consultation on fats and fatty acids in human nutrition: fats and fatty acids in human nutrition: report of an expert consultation; 10–14 November 2008. Geneva, Food and Agriculture Organization of the United Nations, 2010.

  31. Skeaff CM, Hodson L, McKenzie JE. Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. J Nutr. 2006;136:565–9.

    Article  CAS  PubMed  Google Scholar 

  32. Chen YM, Liu Y, Liu YH, Wang X, Guan K, Zhu HL. Higher serum concentrations of betaine rather than choline is associated with better profiles of DXA-derived body fat and fat distribution in Chinese adults. Int J Obes. 2015;39:465–71.

    Article  CAS  Google Scholar 

  33. Zhang CX, Ho SC. Validity and reproducibility of a food frequency questionnaire among Chinese women in Guangdong province. Asia Pac J Clin Nutr. 2009;18:240–50.

    CAS  PubMed  Google Scholar 

  34. Liu B, Woo J, Tang N, Ng K, Ip R, Yu A. Assessment of total energy expenditure in a Chinese population by a physical activity questionnaire: examination of validity. Int J Food Sci Nutr. 2001;52:269–82.

    Article  CAS  PubMed  Google Scholar 

  35. Liu YH, Xu Y, Wen YB, Guan K, Ling WH, He LP, et al. Association of weight-adjusted body fat and fat distribution with bone mineral density in middle-aged chinese adults: a cross-sectional study. PloS One. 2013;8:e63339.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res. 1964;5:600–8.

    Article  CAS  PubMed  Google Scholar 

  37. Lillington JM, Trafford DJ, Makin HL. A rapid and simple method for the esterification of fatty acids and steroid carboxylic acids prior to gas-liquid chromatography. Clin Chim Acta. 1981;111:91–8.

    Article  CAS  PubMed  Google Scholar 

  38. Dai XW, Zhang B, Wang P, Chen CG, Chen YM, Su YX. Erythrocyte membrane n-3 fatty acid levels and carotid atherosclerosis in Chinese men and women. Atherosclerosis. 2014;232:79–85.

    Article  CAS  PubMed  Google Scholar 

  39. Li L, Wang C, Bao Y, Peng L, Gu H, Jia W. Optimal body fat percentage cut-offs for obesity in Chinese adults. Clin Exp Pharmacol Physiol. 2012;39:393–8.

    Article  CAS  PubMed  Google Scholar 

  40. Tang QQ, Lane MD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem. 2012;81:715–36.

    Article  CAS  PubMed  Google Scholar 

  41. Hanada H, Morikawa K, Hirota K, Nonaka M, Umehara Y. Induction of apoptosis and lipogenesis in human preadipocyte cell line by n-3 PUFAs. Cell Biol Int. 2011;35:51–9.

    CAS  PubMed  Google Scholar 

  42. Kim HK, Della-Fera M, Lin J, Baile CA. Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. J Nutr. 2006;136:2965–9.

    Article  CAS  PubMed  Google Scholar 

  43. Martinez-Fernandez L, Laiglesia LM, Huerta AE, Martinez JA, Moreno-Aliaga MJ. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. Prostaglandins Other Lipid Mediat. 2015;121:24–41.

    Article  CAS  PubMed  Google Scholar 

  44. Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, Franssen-van Hal N, et al. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia. 2005;48:2365–75.

    Article  CAS  PubMed  Google Scholar 

  45. Vazquez-Vela MEF, Torres N, Tovar AR. White adipose tissue as endocrine organ and its role in obesity. Arch Med Res. 2008;39:715–28.

    Article  CAS  PubMed  Google Scholar 

  46. Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M, et al. Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol. 2007;27:1918–25.

    Article  CAS  PubMed  Google Scholar 

  47. Huerta AE, Navas-Carretero S, Prieto-Hontoria PL, Martinez JA, Moreno-Aliaga MJ. Effects of alpha-lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss. Obesity. 2015;23:313–21.

    Article  CAS  PubMed  Google Scholar 

  48. Mori TA, Burke V, Puddey IB, Watts GF, O ‘Neal DN, Best JD, et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr. 2000;71:1085–94.

    Article  CAS  PubMed  Google Scholar 

  49. So J, Wu D, Lichtenstein A, Lamon-Fava S. Docosahexaenoic acid and eicosapentaenoic acid supplementation differentially modulate pro- and anti-inflammatory cytokines in subjects with chronic inflammation (OR29-02-19). Curr Dev Nutr. 2019;3(Suppl 1):489.

    Google Scholar 

  50. Cottin SC, Sanders TA, Hall WL. The differential effects of EPA and DHA on cardiovascular risk factors. Proc Nutr Soc. 2011;70:215–31.

    Article  CAS  PubMed  Google Scholar 

  51. Snijder MB, Visser M, Dekker JM, Seidell JC, Fuerst T, Tylavsky F, et al. The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. International journal of obesity and related metabolic disorders. Int J Obes Relat Metab Disord. 2002;26:984–93.

    Article  CAS  PubMed  Google Scholar 

  52. Mohammad A, De Lucia Rolfe E, Sleigh A, Kivisild T, Behbehani K, Wareham NJ, et al. Validity of visceral adiposity estimates from DXA against MRI in Kuwaiti men and women. Nutr Diabetes. 2017;7:e238.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Willett W. Nutritional epidemiology, 3rd ed. Oxford University Press: New York, New York; 2013.

  54. Mocking RJT, Assies J, Lok A, Ruhe HG, Koeter MWJ, Visser I, et al. Statistical methodological issues in handling of fatty acid data: percentage or concentration. imputation and indices. Lipids. 2012;47:541–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all the participants and the coordination staff in the GNHS cohort study gratefully.

Funding

This study was supported by National Science Foundation of China (Nos. 81773416, 81472965, 81602853); the 5010 Programme for Clinical Researches (No. 2007032) by the Sun Yat-sen University. The funders had no role in study design, the collection, analysis and interpretation of data, the writing of the report, and in the decision to submit the article for publication.

Author information

Authors and Affiliations

Authors

Contributions

YMC conceived and designed the research; YHL, TYS, YYW, CFL, CWL, FFZ collected the data; YHL performed the data analysis and wrote the paper; YMC critically revised the manuscript and had primary responsibility for final content. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yu-ming Chen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Yh., Sun, Ty., Wu, Yy. et al. Higher erythrocyte n-3 polyunsaturated fatty acid were associated with a better profile of DXA-derived body fat and fat distribution in adults. Int J Obes 44, 1884–1892 (2020). https://doi.org/10.1038/s41366-020-0569-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41366-020-0569-8

This article is cited by

Search

Quick links